These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22578908)

  • 1. Thromboembolic risk in atrial flutter resembles non-valvular atrial fibrillation (insights from transesophageal echocardiography).
    Providência R
    Am J Cardiol; 2012 Jun; 109(11):1686-7. PubMed ID: 22578908
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic differences between atrial fibrillation and atrial flutter.
    Lelorier P; Humphries KH; Krahn A; Connolly SJ; Talajic M; Green M; Sheldon R; Dorian P; Newman D; Kerr CR; Yee R; Klein GJ
    Am J Cardiol; 2004 Mar; 93(5):647-9. PubMed ID: 14996602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation in atrial fibrillation and flutter.
    Scholten MF; Thornton AS; Mekel JM; Koudstaal PJ; Jordaens LJ
    Europace; 2005 Sep; 7(5):492-9. PubMed ID: 16087116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of transesophageal echocardiography to confirm clinical utility of CHA2DS2-VASc and CHADS2 scores in atrial flutter.
    Parikh MG; Aziz Z; Krishnan K; Madias C; Trohman RG
    Am J Cardiol; 2012 Feb; 109(4):550-5. PubMed ID: 22133753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of thromboembolism in acute atrial fibrillation or atrial flutter.
    Stoddard MF
    Echocardiography; 2000 May; 17(4):393-405. PubMed ID: 10979012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining thromboembolic risk prediction in non-valvular atrial fibrillation with echocardiography: a call to arms.
    Choong CY
    J Am Soc Echocardiogr; 2011 May; 24(5):520-5. PubMed ID: 21514502
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of atrial fibrillation burden in assessing thromboembolic risk.
    Zimetbaum P; Waks JW; Ellis ER; Glotzer TV; Passman RS
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1223-9. PubMed ID: 25516580
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and echocardiographic measures governing thromboembolism destination in atrial fibrillation.
    McBane RD; Hodge DO; Wysokinski WE
    Thromb Haemost; 2008 May; 99(5):951-5. PubMed ID: 18449427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of lone atrial flutter.
    Halligan SC; Gersh BJ; Brown RD; Rosales AG; Munger TM; Shen WK; Hammill SC; Friedman PA
    Ann Intern Med; 2004 Feb; 140(4):265-8. PubMed ID: 14970149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of transesophageal echocardiography in the therapeutic management of non-valvular atrial fibrillation].
    Baubion N
    Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1291-5. PubMed ID: 8952827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative incidence of protrusive atheromatous plaques of the thoracic artery in patients with atrial fluter and atrial fibrillation].
    Boccara F; Rozenberg V; Buyukoglu B; Smadja C; Bardet J; Cohen A
    Arch Mal Coeur Vaiss; 2001 Jan; 94(1):16-22. PubMed ID: 11233476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioversion of persistent atrial flutter in non-anticoagulated patients at low risk for thromboembolism.
    Bertaglia E; D'Este D; Franceschi M; Pascotto P
    Ital Heart J; 2000 May; 1(5):349-53. PubMed ID: 10832811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 14. Summaries for patients. Outcomes of patients with lone atrial flutter.
    Ann Intern Med; 2004 Feb; 140(4):I55. PubMed ID: 14970172
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thromboembolic risk factors in atrial flutter. Transesophageal echocardiographic study].
    Thumala A; Parra C; Maragaño P; Puelma A; Florenzano F
    Rev Med Chil; 2000 Dec; 128(12):1327-34. PubMed ID: 11227241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to define valvular atrial fibrillation?
    Fauchier L; Philippart R; Clementy N; Bourguignon T; Angoulvant D; Ivanes F; Babuty D; Bernard A
    Arch Cardiovasc Dis; 2015 Oct; 108(10):530-9. PubMed ID: 26184867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study).
    Thambidorai SK; Murray RD; Parakh K; Shah TK; Black IW; Jasper SE; Li J; Apperson-Hansen C; Asher CR; Grimm RA; Klein AL;
    Am J Cardiol; 2005 Oct; 96(7):935-41. PubMed ID: 16188520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study.
    Manning WJ; Silverman DI; Keighley CS; Oettgen P; Douglas PS
    J Am Coll Cardiol; 1995 May; 25(6):1354-61. PubMed ID: 7722133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk stratification tools for evaluating thromboembolic risk in atrial fibrillation].
    Ouardiri Y; Marti C; Carballo S; Garin N
    Rev Med Suisse; 2011 Feb; 7(280):313-6, 318-9. PubMed ID: 21381276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transesophageal echocardiography and atrial fibrillation: added value or expensive toy?
    Manning WJ; Douglas PS
    Ann Intern Med; 1998 Apr; 128(8):685-7. PubMed ID: 9537943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.